Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on September 17, 2008
J Am Soc Nephrol 20: 933-939, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008040402
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008040402v1
20/5/933    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlaich, M. P.
Right arrow Articles by Lambert, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlaich, M. P.
Right arrow Articles by Lambert, G. W.

Brief Review

Sympathetic Activation in Chronic Renal Failure

Markus P. Schlaich, Flora Socratous, Sarah Hennebry, Nina Eikelis, Elisabeth A. Lambert, Nora Straznicky, Murray D. Esler and Gavin W. Lambert

Neurovascular Hypertension and Kidney Disease Laboratory, Baker Heart Research Institute, Melbourne, Australia

Correspondence: Prof. Markus P. Schlaich, Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart Research Institute, P.O. Box 6492 St. Kilda Road Central, Melbourne VIC 8008, Australia. Phone: ++61-3-8532-1502; Fax: ++61-3-8532-1100; E-mail: markus.schlaich{at}baker.edu.au

The potential involvement of sympathetic overactivity has been neglected in this population despite accumulating experimental and clinical evidence suggesting a crucial role of sympathetic activation for both progression of renal failure and the high rate of cardiovascular events in patients with chronic kidney disease. The contribution of sympathetic neural mechanisms to the occurrence of cardiac arrhythmias, the development of hypertension, and the progression of heart failure are well established; however, the exact mechanisms contributing to heightened sympathetic tone in patients with chronic kidney disease are unclear. This review analyses potential mechanisms underlying sympathetic activation in chronic kidney disease, the range of adverse consequences associated with this activation, and potential therapeutic implications resulting from this relationship.




This article has been cited by other articles:


Home page
 HypertensionHome page
M. P. Schlaich, P. A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M. D. Esler
Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept
Hypertension, December 1, 2009; 54(6): 1195 - 1201.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. C. Luft
Not so free associations
Nephrol. Dial. Transplant., September 30, 2009; (2009) gfp509v1.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673